カテゴリー： 世界, 医療/バイオ, IMARC

世界の潰瘍性大腸炎市場予測2023年-2028年

【英語タイトル】Ulcerative Colitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが出版した調査資料（IMARC23OT0154）・商品コード：IMARC23OT0154
・発行会社（調査会社）：IMARC
・発行日：2023年9月27日
・ページ数：146
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥449,850見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥599,850見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥749,850見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

市場概要潰瘍性大腸炎の世界市場規模は2022年に74億米ドルに達しました。今後、IMARC Groupでは、2023年から2028年にかけての成長率（CAGR）は5.4%で、2028年には102億米ドルに達すると予測しています。

潰瘍性大腸炎（UC）は、消化管の炎症、炎症、潰瘍（ただれ）を引き起こす慢性の炎症性腸疾患（IBD）です。通常、大腸（または結腸）と直腸の内壁が侵されます。一般的に症状は時間とともに進行し、UCと診断された患者さんでは、症状が軽かったり、全くなかったりする期間もあります。しかし、時には衰弱や生命を脅かす合併症を引き起こすこともあります。UCを完治させる治療法はまだありませんが、治療によって患者さんの症状を管理・軽減し、再燃を防ぎ、長期的な寛解をもたらすことができます。その結果、潰瘍性大腸炎の治療は、患者の生活の質を高め、肉体的・精神的な健康を確保するのに役立つため、世界中で急速に普及しています。

潰瘍性大腸炎市場の動向：UC疾患の広範な有病率と、利用可能な治療オプションに関する認知度の高まりが、市場成長を促進する主な要因となっています。これに加えて、強力なパイプライン製品の存在と、多数の薬剤における継続的な進歩が、製品需要を増大させています。さらに、各国政府は、この疾患に関する認識を広め、適切な医療施設へのアクセスや利用可能性を高めるために、いくつかのイニシアチブを取っています。これは、新規治療法の開発のための研究開発（R&D）活動への投資の増加と相まって、市場の成長を促進しています。さらに、大手企業は製品ポートフォリオを拡大し、市場での競争力を高めるため、革新的でより効果的な医薬品の上市に注力しています。バイオシミラー医薬品の容易な入手可能性、医療インフラの改善、有利な償還政策、医療に対する消費支出の増加など、その他の要因も市場の見通しを明るいものにしています。

主要市場細分化：IMARC Groupは、潰瘍性大腸炎の世界市場レポートの各サブセグメントにおける主要動向の分析を、2023年から2028年までの世界、地域、国レベルでの予測とともに提供しています。当レポートでは、市場をタイプ別、疾患タイプ別、分子タイプ別、薬剤タイプ別、投与経路別、流通チャネル別に分類しています。

タイプ別内訳
軽度UC
中等度UC
重症UC

疾患タイプ別内訳
潰瘍性直腸炎
直腸S状結腸炎
左側大腸炎
膵炎または万能性大腸炎
劇症型大腸炎

分子タイプ別内訳
低分子
生物製剤

薬剤タイプ別内訳
抗炎症薬
抗TNF生物製剤
免疫抑制剤
カルシニューリン阻害薬
その他

投与経路別内訳
経口
注射剤

流通経路別内訳
病院薬局
小売薬局
ドラッグストア
その他

地域別内訳
北米
米国
カナダ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中東・アフリカ

競合情勢：業界の競合情勢も、Abbott Laboratories, AbbVie Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.などの企業情報が含まれています。

本レポートで扱う主な質問：潰瘍性大腸炎の世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
COVID-19が世界の潰瘍性大腸炎市場に与えた影響は？
主要な地域市場は？
タイプ別の市場の内訳は？
疾患タイプ別内訳は？
分子タイプに基づく市場の内訳は？
薬剤タイプ別の市場内訳は？
投与経路に基づく市場の内訳は？
販売チャネルに基づく市場の内訳は？
業界のバリューチェーンにおける様々な段階とは？
業界の主な推進要因と課題は？
潰瘍性大腸炎の世界市場構造と主要プレイヤーは？
業界における競争の程度は？

1 序論
2 調査範囲・方法
3 エグゼクティブサマリー
4 イントロダクション
5 潰瘍性大腸炎の世界市場
6 タイプ別市場分析
7 疾患タイプ別市場分析
8 分子タイプ別市場分析
9 薬剤タイプ別市場分析
10 投与経路別市場分析
11 流通チャネル別市場分析
12 地域別市場分析
13 SWOT分析
14 バリューチェーン分析
15 ポーターズファイブフォース分析
16 価格分析
17 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Ulcerative Colitis Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Mild UC
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Moderate UC
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Severe UC
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Disease Type
7.1 Ulcerative Proctitis
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Proctosigmoiditis
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Left-sided Colitis
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Pancolitis or Universal Colitis
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Fulminant Colitis
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Molecule Type
8.1 Small Molecules
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Biologics
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Drug Type
9.1 Anti-Inflammatory Drugs
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Anti-TNF Biologics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Immunosuppressant
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Calcineurin Inhibitors
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Route of Administration
10.1 Oral
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Injectable
10.2.1 Market Trends
10.2.2 Market Forecast
11 Market Breakup by Distribution Channel
11.1 Hospital Pharmacies
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Retail Pharmacies
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Drug Store
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Others
11.4.1 Market Trends
11.4.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia-Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 Abbott Laboratories
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.1.3 Financials
17.3.1.4 SWOT Analysis
17.3.2 AbbVie Inc.
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.2.3 Financials
17.3.2.4 SWOT Analysis
17.3.3 AstraZeneca plc
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.3.3 Financials
17.3.3.4 SWOT Analysis
17.3.4 Bristol-Myers Squibb Company
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
17.3.4.3 Financials
17.3.4.4 SWOT Analysis
17.3.5 Eli Lilly and Company
17.3.5.1 Company Overview
17.3.5.2 Product Portfolio
17.3.5.3 Financials
17.3.5.4 SWOT Analysis
17.3.6 F. Hoffmann-La Roche Ltd.
17.3.6.1 Company Overview
17.3.6.2 Product Portfolio
17.3.6.3 Financials
17.3.7 GlaxoSmithKline plc
17.3.7.1 Company Overview
17.3.7.2 Product Portfolio
17.3.7.3 Financials
17.3.7.4 SWOT Analysis
17.3.8 Johnson & Johnson
17.3.8.1 Company Overview
17.3.8.2 Product Portfolio
17.3.8.3 Financials
17.3.8.4 SWOT Analysis
17.3.9 Merck & Co. Inc.
17.3.9.1 Company Overview
17.3.9.2 Product Portfolio
17.3.9.3 Financials
17.3.9.4 SWOT Analysis
17.3.10 Pfizer Inc.
17.3.10.1 Company Overview
17.3.10.2 Product Portfolio
17.3.10.3 Financials
17.3.10.4 SWOT Analysis
17.3.11 Takeda Pharmaceutical Company Limited
17.3.11.1 Company Overview
17.3.11.2 Product Portfolio
17.3.11.3 Financials
17.3.11.4 SWOT Analysis
17.3.12 Teva Pharmaceutical Industries Ltd.
17.3.12.1 Company Overview
17.3.12.2 Product Portfolio
17.3.12.3 Financials
17.3.12.4 SWOT Analysis

Figure 1: Global: Ulcerative Colitis Market: Major Drivers and Challenges
Figure 2: Global: Ulcerative Colitis Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Ulcerative Colitis Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Ulcerative Colitis Market: Breakup by Type (in %), 2022
Figure 5: Global: Ulcerative Colitis Market: Breakup by Disease Type (in %), 2022
Figure 6: Global: Ulcerative Colitis Market: Breakup by Molecule Type (in %), 2022
Figure 7: Global: Ulcerative Colitis Market: Breakup by Drug Type (in %), 2022
Figure 8: Global: Ulcerative Colitis Market: Breakup by Route of Administration (in %), 2022
Figure 9: Global: Ulcerative Colitis Market: Breakup by Distribution Channel (in %), 2022
Figure 10: Global: Ulcerative Colitis Market: Breakup by Region (in %), 2022
Figure 11: Global: Ulcerative Colitis (Mild UC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Ulcerative Colitis (Mild UC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Ulcerative Colitis (Moderate UC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Ulcerative Colitis (Moderate UC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Ulcerative Colitis (Severe UC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Ulcerative Colitis (Severe UC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Ulcerative Colitis (Ulcerative Proctitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Ulcerative Colitis (Ulcerative Proctitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Ulcerative Colitis (Proctosigmoiditis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Ulcerative Colitis (Proctosigmoiditis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Ulcerative Colitis (Left-sided Colitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Ulcerative Colitis (Left-sided Colitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Ulcerative Colitis (Pancolitis or Universal Colitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Ulcerative Colitis (Pancolitis or Universal Colitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Ulcerative Colitis (Fulminant Colitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Ulcerative Colitis (Fulminant Colitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Ulcerative Colitis (Small Molecules) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Ulcerative Colitis (Small Molecules) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Ulcerative Colitis (Biologics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Ulcerative Colitis (Biologics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Ulcerative Colitis (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Ulcerative Colitis (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Ulcerative Colitis (Anti-TNF Biologics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Ulcerative Colitis (Anti-TNF Biologics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Ulcerative Colitis (Immunosuppressant) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Ulcerative Colitis (Immunosuppressant) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Ulcerative Colitis (Calcineurin Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Ulcerative Colitis (Calcineurin Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Ulcerative Colitis (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Ulcerative Colitis (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Ulcerative Colitis (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Ulcerative Colitis (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Global: Ulcerative Colitis (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Global: Ulcerative Colitis (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Global: Ulcerative Colitis (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Global: Ulcerative Colitis (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Global: Ulcerative Colitis (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Global: Ulcerative Colitis (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Global: Ulcerative Colitis (Drug Store) Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Global: Ulcerative Colitis (Drug Store) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Global: Ulcerative Colitis (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Global: Ulcerative Colitis (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: North America: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: North America: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: United States: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: United States: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Canada: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Canada: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Asia-Pacific: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Asia-Pacific: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: China: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: China: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Japan: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Japan: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: India: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: India: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: South Korea: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: South Korea: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Australia: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Australia: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Indonesia: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Indonesia: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Europe: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Europe: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Germany: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Germany: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: France: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: France: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: United Kingdom: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: United Kingdom: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Italy: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Italy: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Spain: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Spain: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Russia: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Russia: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Others: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Others: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Latin America: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 92: Latin America: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 93: Brazil: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 94: Brazil: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 95: Mexico: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 96: Mexico: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 97: Others: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 98: Others: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 99: Middle East and Africa: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 100: Middle East and Africa: Ulcerative Colitis Market: Breakup by Country (in %), 2022
Figure 101: Middle East and Africa: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 102: Global: Ulcerative Colitis Industry: SWOT Analysis
Figure 103: Global: Ulcerative Colitis Industry: Value Chain Analysis
Figure 104: Global: Ulcerative Colitis Industry: Porter's Five Forces Analysis

Table 1: Global: Ulcerative Colitis Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Ulcerative Colitis Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Ulcerative Colitis Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
Table 4: Global: Ulcerative Colitis Market Forecast: Breakup by Molecule Type (in Million US$), 2023-2028
Table 5: Global: Ulcerative Colitis Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
Table 6: Global: Ulcerative Colitis Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 7: Global: Ulcerative Colitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 8: Global: Ulcerative Colitis Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 9: Global: Ulcerative Colitis Market: Competitive Structure
Table 10: Global: Ulcerative Colitis Market: Key Players

★調査レポート[世界の潰瘍性大腸炎市場予測2023年-2028年] (コード：IMARC23OT0154)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の潰瘍性大腸炎市場予測2023年-2028年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の消化管治療薬市場予測2023年-2028年
  • 世界の大腸内視鏡検査装置市場予測2023年-2028年
  • 世界のモノクローナル抗体市場予測2022年-2028年
  • 世界の血液悪性腫瘍市場予測2023年-2028年
  • 世界の血液浄化装置市場予測2023年-2028年
  • 世界の生物製剤市場予測2023年-2028年
  • 世界の早期毒性試験市場予測2023年-2028年
  • 世界の高脂血症治療薬市場予測2023年-2028年

    • ◆H&Iグローバルリサーチのお客様（例）◆